106 related articles for article (PubMed ID: 1430968)
21. Bacillary dysentery. An institutional outbreak of Shigella sonnei: treatment of 36 cases with nalidixic acid.
Fernandez LA
J Kans Med Soc; 1966 Jul; 67(7):359-60 passim. PubMed ID: 5330682
[No Abstract] [Full Text] [Related]
22. Emergence of nalidixic acid resistance in Shigella sonnei isolated from patients having acute diarrheal disease: report from eastern province of Saudi Arabia.
Panhotra BR; Saxena AK; Al-Mulhim K
Jpn J Infect Dis; 2004 Jun; 57(3):116-8. PubMed ID: 15218222
[TBL] [Abstract][Full Text] [Related]
23. Serogroup prevalence of Shigellae in Bombay.
Sonawala M; Saraswathi K; Deodhar LP
J Postgrad Med; 1995; 41(4):104-6. PubMed ID: 10707731
[TBL] [Abstract][Full Text] [Related]
24. Norfloxacin versus nalidixic acid in the treatment of urinary tract infections.
Karachalios GN; Georgiopoulos AN
Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):317-9. PubMed ID: 3623736
[TBL] [Abstract][Full Text] [Related]
25. [Effect of fluoroquinolones made in China in the treatment of acute bacillary dysentery. A report of 212 cases].
Wang XF; Jiang SC; Wei YL
Zhonghua Nei Ke Za Zhi; 1990 Aug; 29(8):482-4, 511. PubMed ID: 2086018
[TBL] [Abstract][Full Text] [Related]
26. Drug resistant shigellosis in south India.
Paniker CK; Vimala KN; Bhat P; Stephen S
Indian J Med Res; 1978 Sep; 68():413-7. PubMed ID: 744630
[No Abstract] [Full Text] [Related]
27. Antibiotics in the management of shigellosis.
Wkly Epidemiol Rec; 2004 Sep; 79(39):355-6. PubMed ID: 15571173
[No Abstract] [Full Text] [Related]
28. Serodiversity and antimicrobial resistance pattern of Shigella isolates at Gondar University teaching hospital, Northwest Ethiopia.
Tiruneh M
Jpn J Infect Dis; 2009 Mar; 62(2):93-7. PubMed ID: 19305047
[TBL] [Abstract][Full Text] [Related]
29. Treatment of bacillary dysentery: a comparison between enoxacin and nalidixic acid.
De Mol P; Mets T; Lagasse R; Vandepitte J; Mutwewingabo A; Butzler JP
J Antimicrob Chemother; 1987 May; 19(5):695-8. PubMed ID: 3301783
[TBL] [Abstract][Full Text] [Related]
30. Changing patterns of serotypes and antimicrobial susceptibilities of Shigella species isolated from children in Calcutta, India.
Niyogi SK; Mitra U; Dutta P
Jpn J Infect Dis; 2001 Jun; 54(3):121-2. PubMed ID: 11544405
[No Abstract] [Full Text] [Related]
31. Existing status of shigellosis in Andaman & Nicobar islands.
Ghosh AR; Sehgal SC
Indian J Med Res; 1996 Mar; 103():134-7. PubMed ID: 9062037
[TBL] [Abstract][Full Text] [Related]
32. Randomized double-blind trial of high- and low-dose fleroxacin versus norfloxacin for complicated urinary tract infection.
Pittman W; Moon JO; Hamrick LC; Cox CE; Clark J; Childs S; Pizzuti D; Fredericks J; St Clair P
Am J Med; 1993 Mar; 94(3A):101S-104S. PubMed ID: 8452163
[TBL] [Abstract][Full Text] [Related]
33. Short-course norfloxacin and trimethoprim-sulfamethoxazole treatment of shigellosis and salmonellosis in Egypt.
Bassily S; Hyams KC; el-Masry NA; Farid Z; Cross E; Bourgeois AL; Ayad E; Hibbs RG
Am J Trop Med Hyg; 1994 Aug; 51(2):219-23. PubMed ID: 8074256
[TBL] [Abstract][Full Text] [Related]
34. A clinical study of wintomylon in the treatment of shigellosis.
Yu PC; Chen HS
Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1965; 6(3):127-31. PubMed ID: 5861506
[No Abstract] [Full Text] [Related]
35. Occurrence of shigellosis in the young and elderly in rural China: results of a 12-month population-based surveillance study.
Wang XY; Du L; Von Seidlein L; Xu ZY; Zhang YL; Hao ZY; Han OP; Ma JC; Lee HJ; Ali M; Han CQ; Xing ZC; Chen JC; Clemens J
Am J Trop Med Hyg; 2005 Aug; 73(2):416-22. PubMed ID: 16103614
[TBL] [Abstract][Full Text] [Related]
36. Increasing resistance to nalidixic acid in Shigella subgroups in a comparative study between 2001-2003 and 2004-2006.
Mamishi S; Mashoori N; Mahboobi N; Pour Akbari B
Singapore Med J; 2009 Aug; 50(8):791-3. PubMed ID: 19710978
[TBL] [Abstract][Full Text] [Related]
37. Nalidixic-acid-resistant Shigella dysenteriae I.
Panhotra BR; Desai B; Sharma PL
Lancet; 1985 Mar; 1(8431):763. PubMed ID: 2858035
[No Abstract] [Full Text] [Related]
38. Comparison of single-dose treatment with norfloxacin and standard 5-day treatment with trimethoprim-sulfamethoxazole for acute shigellosis in adults.
Gotuzzo E; Oberhelman RA; Maguiña C; Berry SJ; Yi A; Guzman M; Ruiz R; Leon-Barua R; Sack RB
Antimicrob Agents Chemother; 1989 Jul; 33(7):1101-4. PubMed ID: 2675757
[TBL] [Abstract][Full Text] [Related]
39. Death from multi-resistant shigelloses: a case study from Fiji.
Watson C
Pac Health Dialog; 2006 Sep; 13(2):111-4. PubMed ID: 18181399
[TBL] [Abstract][Full Text] [Related]
40. [Comparative bacteriologic activity of norfloxacin, ofloxacin and pefloxacin against 320 Gram-negative bacilli resistant and non-resistant to nalidixic acid and cephalosporins].
Croize J; Le Noc P; Bryskier A; Robert J
Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):564-8. PubMed ID: 3937128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
